Andhra Cements Ltd

AI

Andhra Cements Ltd

₹ 44.4 -0.36%
26 Aug 11:21 a.m.
About

Incorporated in 1936, Andhra Cements Ltd is in the business of manufacturing and selling cement[1]

Key Points

Corporate History & Ownership Changes[1]
Andhra Cements Limited has undergone multiple ownership transitions over the years from the Bennett Coleman Group to the Duncan Goenka Group in 1994, followed by the Jaypee Group in 2012. Following severe financial stress and plant shutdowns between 2020-2023, the company underwent CIRP. In Feb'23, the NCLT approved the resolution plan of Sagar Cements Ltd., which infused Rs. 322 Crs. and acquired control of the company. Andhra Cements is now a subsidiary of Sagar Cements[2] and part of the Sagar Group.

  • Market Cap 409 Cr.
  • Current Price 44.4
  • High / Low 110 / 40.4
  • Stock P/E
  • Book Value 8.76
  • Dividend Yield 0.00 %
  • ROCE -6.01 %
  • ROE -64.0 %
  • Face Value 10.0

Pros

  • Company is expected to give good quarter

Cons

  • Stock is trading at 5.09 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -47.2% over last 3 years.
  • Promoters have pledged 31.7% of their holding.
  • Earnings include an other income of Rs.10.0 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
13 65 98 92 63 55 66 89 100 78 110 155 142
24 57 93 96 69 65 75 95 93 82 105 146 138
Operating Profit -11 8 5 -5 -5 -10 -8 -5 7 -4 5 9 4
OPM % -83% 12% 4.7% -5% -8% -19% -13% -6% 7% -6% 4.6% 6% 2.6%
0 15 0 7 5 1 2 -7 1 1 1 8 1
Interest 14 19 20 18 18 18 19 20 21 21 26 30 32
Depreciation 13 13 16 15 17 18 18 18 17 17 23 27 21
Profit before tax -38 -9 -31 -30 -36 -45 -44 -50 -30 -42 -44 -41 -48
Tax % -34% -89% -31% -37% -35% -22% 0% 0% 0% 0% 0% -219% -25%
-25 -1 -21 -19 -24 -35 -44 -50 -30 -42 -44 49 -36
EPS in Rs -2.68 -0.11 -2.30 -2.04 -2.56 -3.78 -4.74 -5.41 -3.21 -4.55 -4.79 5.26 -3.90
Raw PDF

Profit & Loss

Figures in Rs. Crores

Jun 2015 15m Mar 2016 9m Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
278 292 349 466 321 143 0 0 0 268 274 442 485
253 258 310 411 308 151 29 31 25 271 303 426 472
Operating Profit 25 34 39 55 13 -8 -29 -31 -25 -3 -29 16 13
OPM % 9% 12% 11% 12% 4.1% -5% -29,240% -1.2% -11% 3.6% 2.7%
-36 3 2 45 -38 1 1 -1 972 23 1 10 10
Interest 62 74 105 127 108 122 130 158 16 71 75 98 109
Depreciation 25 30 40 45 47 48 48 47 47 56 72 84 88
Profit before tax -99 -67 -104 -72 -181 -177 -205 -236 884 -107 -175 -156 -175
Tax % -0% -1% -1% -1% -0% -5% 0% 0% -7% -39% -13% -57%
-99 -67 -103 -71 -180 -168 -205 -236 950 -66 -152 -67 -73
EPS in Rs -3.37 -2.28 -3.51 -2.42 -6.14 -5.73 -6.99 -8.05 103.03 -7.12 -16.50 -7.29 -7.98
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 4%
5 Years: 436%
3 Years: %
TTM: 56%
Compounded Profit Growth
10 Years: -1%
5 Years: 11%
3 Years: %
TTM: 52%
Stock Price CAGR
10 Years: 18%
5 Years: 12%
3 Years: -25%
1 Year: -50%
Return on Equity
10 Years: %
5 Years: %
3 Years: -47%
Last Year: -64%

Balance Sheet

Figures in Rs. Crores

Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 294 294 294 294 294 294 294 294 92 92 92 92
Reserves -151 -255 -358 -428 -608 -774 -974 -1,210 263 205 52 -11
864 903 927 937 960 961 963 970 525 675 757 1,127
364 313 386 420 410 522 656 817 36 107 243 212
Total Liabilities 1,370 1,253 1,249 1,222 1,054 1,003 940 871 917 1,080 1,144 1,420
845 818 777 1,007 973 926 878 832 738 815 759 977
CWIP 265 286 302 30 1 1 1 0 26 0 106 6
Investments 0 0 0 0 0 0 0 0 0 0 0 0
259 150 170 185 80 76 60 39 152 265 280 437
Total Assets 1,370 1,253 1,249 1,222 1,054 1,003 940 871 917 1,080 1,144 1,420

Cash Flows

Figures in Rs. Crores

Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
151 43 55 93 22 117 119 151 -1 -27 60 -25
-207 -17 -3 42 1 0 3 1 -35 -96 -81 -248
62 -34 -55 -119 -45 -118 -122 -152 80 90 11 274
Net Cash Flow 6 -8 -2 16 -22 -0 -0 0 44 -33 -11 0
Free Cash Flow -66 25 52 132 23 117 119 151 -28 -117 -17 -246
CFO/OP 614% 126% 141% 171% 162% -1,508% -405% -492% 4% 809% -203% -155%

Ratios

Figures in Rs. Crores

Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 61 39 28 21 22 51 27,996 52 40 38
Inventory Days 439 202 233 211 141 405 63,551 14,368 930 1,019 398
Days Payable 1,378 791 1,280 1,064 1,075 4,109 771,651 3,208 1,172 2,164 575
Cash Conversion Cycle -878 -550 -1,019 -832 -912 -3,653 -680,104 -190 -1,105 -138
Working Capital Days -358 -322 -316 -269 -742 -2,189 -3,794,504 -34 -248 -85
ROCE % 1% 0% 2% -4% -10% -20% -45% -15% -6% -11% -6%

Insights

In beta
Feb 2012 Dec 2014 Mar 2016 Mar 2023 Mar 2024 Mar 2026
Cement Installed Capacity
MTPA

Log in to view insights

Please log in to see hidden values.

Login
Cement Sales Volume
Tons
Clinker Installed Capacity
MTPA
Limestone Reserves
mnt

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
95.00% 95.00% 90.00% 90.00% 90.00% 90.00% 90.00% 90.00% 90.00% 90.00% 75.00% 75.00%
0.34% 0.34% 0.34% 0.34% 0.34% 0.34% 0.34% 0.34% 0.34% 0.34% 0.34% 0.34%
4.66% 4.66% 9.66% 9.66% 9.65% 9.66% 9.65% 9.66% 9.66% 9.67% 24.65% 24.64%
No. of Shareholders 90,11587,47590,71892,37591,81091,57891,19690,18786,82785,37885,27684,453

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents